Filing Details

Accession Number:
0001140361-22-028234
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-04 18:26:16
Reporting Period:
2022-08-02
Accepted Time:
2022-08-04 18:26:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1113148 Infinity Pharmaceuticals Inc. INFI Pharmaceutical Preparations (2834) 330655706
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1875939 Stephane Peluso C/O Infinity Pharmaceuticals, Inc.
1100 Massachusetts Avenue, Floor 4
Cambridge MA 02138
Chief Scientific Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-08-02 50,000 $0.00 52,046 No 4 M Direct
Common Stock Acquisiton 2022-08-02 14,994 $0.66 37,052 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Disposition 2022-08-02 50,000 $0.00 50,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
Footnotes
  1. Restricted stock units ("RSUs") convert into Common Stock of the issuer on a one-for-one basis. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date.
  2. Represents the shares automatically sold by the reporting person to satisfy tax withholding obligations in connection with the vesting of the RSUs listed in Table II. This sale does not represent a discretionary trade by the reporting person.
  3. On August 2, 2021, the reporting person was granted RSUs, of which all 50,000 vested as of August 2, 2022.